These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16440329)

  • 21. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
    Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
    J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p130(Cas), an assembling molecule of actin filaments, promotes cell movement, cell migration, and cell spreading in fibroblasts.
    Honda H; Nakamoto T; Sakai R; Hirai H
    Biochem Biophys Res Commun; 1999 Aug; 262(1):25-30. PubMed ID: 10448062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-CrkII-DOCK180 pathway.
    Gu J; Sumida Y; Sanzen N; Sekiguchi K
    J Biol Chem; 2001 Jul; 276(29):27090-7. PubMed ID: 11369773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cas utilizes Nck2 to activate Cdc42 and regulate cell polarization during cell migration in response to wound healing.
    Funasaka K; Ito S; Hasegawa H; Goldberg GS; Hirooka Y; Goto H; Hamaguchi M; Senga T
    FEBS J; 2010 Sep; 277(17):3502-13. PubMed ID: 20637038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness.
    Funato Y; Terabayashi T; Suenaga N; Seiki M; Takenawa T; Miki H
    Cancer Res; 2004 Aug; 64(15):5237-44. PubMed ID: 15289329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
    Kain KH; Gooch S; Klemke RL
    Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
    Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells.
    Torka R; Thuma F; Herzog V; Kirfel G
    Exp Cell Res; 2006 Nov; 312(19):3857-71. PubMed ID: 17010335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
    Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proapoptotic function of the nuclear Crk II adaptor protein.
    Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
    Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EphA4 receptor regulates dendritic spine remodeling by affecting beta1-integrin signaling pathways.
    Bourgin C; Murai KK; Richter M; Pasquale EB
    J Cell Biol; 2007 Sep; 178(7):1295-307. PubMed ID: 17875741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
    Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
    Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS.
    Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK
    J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical roles for lysyl oxidases in cancer--a prospect.
    Payne SL; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2007 Aug; 101(6):1338-54. PubMed ID: 17471532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular signaling of Dock family proteins in neural function.
    Miyamoto Y; Yamauchi J
    Cell Signal; 2010 Feb; 22(2):175-82. PubMed ID: 19796679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.
    Shen Q; Rahn JJ; Zhang J; Gunasekera N; Sun X; Shaw AR; Hendzel MJ; Hoffman P; Bernier A; Hugh JC
    Mol Cancer Res; 2008 Apr; 6(4):555-67. PubMed ID: 18403635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180.
    Smith HW; Marra P; Marshall CJ
    J Cell Biol; 2008 Aug; 182(4):777-90. PubMed ID: 18725541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D; Kurisu S; Takenawa T
    Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).
    Makkinje A; Vanden Borre P; Near RI; Patel PS; Lerner A
    J Biol Chem; 2012 Aug; 287(33):27703-14. PubMed ID: 22711540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.